Pharmaceutical
-
Outsourced Pharma Services Could Top $54 Billion
Read the rest of this entry »
The market for global healthcare contract research is growing at a rate approaching 7% a year, and could top $54.7 billion by 2025.
A study from Grand View Research says the growth is the result of increasing drug development costs. Expiring patents, the increasing number of partnerships and rising R&D costs are putting pressure on drug makers. At the same time, the regulatory process in many countries for drug ...
-
2018 Was a Record Year for VC Activity
Read the rest of this entry »
When talking about venture capitalists, California and its Silicon Valley may be the first place to come to mind. In 2018 the state accounted for well over half the $130.9 billion invested. Massachusetts and New York were second and third.
Last year was a record-breaker for VC investment. The Pitchbook declared, "2018 ended up being a banner year for the VC industry with $130.9 billion invested across 8 ...
-
Clinical Trials Suffering From Lack of Skilled Investigators
Read the rest of this entry »The management of clinical drug trials has never been more complex. Changes in trial protocols and development practices are making it increasingly difficult to meet patient enrollment goals. Meanwhile, finding investigators with the experience to work in these trials where drugs are tested on specific genetic mutations, rather than diseases, is harder than ever.
An article in Applied Clinical Trials details the challenges of engaging principal investigators. The article cites ...
-
Consumers Want Amazon to Sell Drugs
Read the rest of this entry »Amazon is the place to shop for everything from electronics to clothing to auto parts and even groceries. And most Amazon shoppers pay $119 a year to get 2-day shipping, Prime video, free photo storage and access to exclusive deals and more.
But what you can't get on Amazon are drugs.
That's likely to change soon, and when it does the giant retailer will have a ready market. An Investing ...
-
Novartis Is Fast Becoming a Data Science Company
Read the rest of this entry »
A year ago, the leader of one the largest pharmaceutical firms in the world said it was transforming itself into a medicines and data science company.
Ever since, Novartis has been hiring data scientists from outside the industry to mine what CEO Vas Narasimhan described as a "goldmine" of data from thousands of studies and trials. In an interview earlier this month, PharmExec discussed this transformation and how the new ...
-
4 Issues Holding AI Back In Life Sciences
Read the rest of this entry »
There's hardly an industry that artificial intelligence hasn't touched. In one form or another -- machine learning, chatbots and predictive analytics, for example -- AI is rapidly becoming a part of all technologies. The life sciences are no exception, though many professionals believe the industry is lagging in its adoption of AI.
Last summer's survey by The Pistoia Alliance found 42% of life sciences professionals doubting that AI has yet proven its ...
-
Biotech and Pharma: Outlook Is Overall Positive
Read the rest of this entry »
For the biotech and pharmaceutical industries, 2018 has proven to be a mixed bag, but with more overall positives than negatives.
In an article reviewing the year so far, and looking ahead to 2019, Peter Young president and managing director of the life science and chemicals investment banking firm Young & Partners, says drug approvals and development escalated and the emergence of new approaches in immuno-oncology, CRISPR, personalized medicine, and ...
-
NYC Offers Life Sciences Internships
Read the rest of this entry »An innovative life sciences internship program in New York City is attracting scores of applications from undergrads and graduate students, competing for access to summer jobs in the city's burgeoning life sciences industry.
The program is just one part of an ambitious, 10-year, $500 million strategy to create 16,000 new life sciences jobs and make New York a leader in the industry. Most of the funding will go to ...
-
Survey: Clinical Trials Are Important, But Hard to Find
Read the rest of this entry »
A global survey of attitudes and perceptions about clinical research trials found both the public and those who have participated in a trial convinced of their importance, but lacking in understanding about how they work and largely uninformed about opportunities for participation.
Conducted by the Center for Information and Study on Clinical Research Participation and published last week on JAMA Network Open, the purpose of the survey was to see ...
-
Market for Clinical Trial Services to Grow 20%
Read the rest of this entry »
Clinical trial services are projected to grow at an annual rate of 12% over the next three years, according to a projection from The Business Research Company. That's a 20% increase over the previous few years.
The report says the growth in outsourcing to contract research organizations (CROs) is the result of cost-cutting by pharmaceutical and biotechnology companies, which has led many of them to outsource parts of their drug ...
